Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1991-10-16
1993-03-30
Cashion, Jr., Merrell C.
Drug, bio-affecting and body treating compositions
Lymphokine
514 2, 514 21, 5303871, 530414, 530833, A61K 39395, A61K 3520
Patent
active
051982137
ABSTRACT:
Whey derived from ordinary milk includes a bottom fraction including lactose and minerals, a middle fraction including lower molecular weight proteins, and a top fraction including higher molecular weight proteins. The top whey fraction includes a measurable but low level concentration of immunologically active immunoglobulin plus other pathogen specific antibodies. The whey is ultrafiltered through one or more different process steps to yield a filtered product having a concentration of immunologically active immunoglobulin of at least about seven percent of total solids. The filtered product is periodically tested to verify its activity to a specified microbe. The filtered product is orally administered in a therapeutically effective dose to an animal to treat a disease.
REFERENCES:
patent: 3128230 (1964-04-01), Heinbach
patent: 3376198 (1969-04-01), Peterson et al.
patent: 3487064 (1969-12-01), Swanson et al.
patent: 3547900 (1970-12-01), Dienst et al.
patent: 3553317 (1971-01-01), Michaelson et al.
patent: 3687682 (1972-08-01), Scheder
patent: 3687928 (1972-08-01), Brouwer et al.
patent: 3707770 (1973-01-01), Timmins et al.
patent: 3791283 (1974-02-01), Moreno et al.
patent: 3911108 (1975-10-01), Singh
patent: 3930039 (1975-12-01), Kiupers
patent: 3969336 (1976-07-01), Criswell
patent: 3969337 (1976-07-01), Lauer et al.
patent: 3975517 (1976-08-01), Wilson
patent: 4042575 (1977-08-01), Eustache
patent: 4784850 (1988-11-01), Abraham
patent: 4816252 (1989-03-01), Stott et al.
patent: 4834974 (1989-05-01), Stott et al.
Advertisement, "Concentrated colostrum from whey. New product ends time consuming collection methods," BEEF, Feb., 1987, p. 52.
Arschaffenberg, R. et al., "The nutritive value of colostrum for the calf. 4. The effect of small quantities of colostral whey, dialyzed whey and `immune lactoglobulins`," Br. J. Nutr. 5: 171 (1951).
Cruywagen, C. W., "Effect of curd forming of colostrum on absorption of immunoglobulin G in newborn calves," J. DairySci. 73(11): 3287 (1990).
de Wit, J. N. et al., "Evaluation of functional properties of whey protein concentrates and whey protein isolates. I. Isolation and characterization," Neth. Milk Dairy J. 37: 37 (1983).
Haines, D. M. et al., "Immunoglobulin concentrations in commercially available colostrum supplements for calves," Can. Vet. J. 31: 36 (1990a).
Haines, D. M. et al., Authors' reply to letter of Dennis A. Nelson, Can. Vet. J. 31: 338 (1990b).
Mutilangi., W. A. M. and Kilara, A., "Functional properties of heat-denatured whey proteins. II. Emulsion and foaming properties," Milchwissenschaft 40(7): 391 (1985).
Renner, E. and El-Salam, M. H., Application of Ultrafiltration in the Dairy Industry, Elsevier Science Publishers Limited, Barking, Essex, England, pp. 218-226 (1991).
Roy, J. H. B., "Symposium: disease prevention in calves. Factors affecting susceptibility of calves to disease.," J. Dairy Sci. 63: 650 (1980).
Lucas David O.
Stott Gerald H.
Cashion Jr. Merrell C.
Protein Technology, Inc.
Touzeau P. L.
LandOfFree
Method of disease treatment utilizing an immunologically whey fr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of disease treatment utilizing an immunologically whey fr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of disease treatment utilizing an immunologically whey fr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1279713